Portfolio company
UTERINE FIBROID TREATMENT
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This medical technology company develops a minimally invasive, uterus-sparing radiofrequency ablation system for women suffering from symptomatic uterine fibroids.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ablatus Therapeutics
This company develops a bimodal electric tissue ablation medical device to treat tumours and uterine fibroids for surgical patients.
Interlace Medical
This company develops medical devices for gynaecological surgeons to remove uterine fibroids and polyps in office-based procedures.
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
May Health
This medical device company develops a minimally invasive ovarian ablation treatment to restore ovulation for women with polycystic ovary syndrome and related infertility.
Channel Medsystems
This medical technology company develops a cryotherapy device for women suffering from heavy menstrual bleeding to enable treatment in a physician's office.
Trod Medical
The company develops radio frequency ablation devices for treating prostate cancer for use by urological surgeons and healthcare providers.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
CAD TREATMENT OPTIMIZATION
This medical technology company develops advanced intravascular imaging systems to help cardiologists assess and treat coronary artery disease in patients.
